Lidings’ dispute resolution practice partner Stepan Guzey will take part in a virtual Arbitration & Fraud in Russia & CIS Conference. The event is scheduled to take place on 13-14 April 2021.

During a lengthy five-year bankruptcy of the pharmaceutical distributor Grama LLC, the bankruptcy manager challenged transactions with suppliers - large international pharmaceutical companies. Worst-hit was AstraZeneca Pharmaceuticals obliged to return the bankrupt distributor 266 million rubles. Lidings represents the company since 2019.

Currently the Draft Law No. 992331-7 is considered by the Russian Federation State Duma. Perhaps it is the most anticipated document in the field of personal data since the proposed changes in 152-FZ are designed to reduce the number of pain points for both operators and consultants in the information protection sphere.

The new review of the most notable patents disputes in Life Sciences in EAEU, CIS and Eastern Europe.

• pdf, 3.02 Mb

The Supreme Court in its Review as of on judicial practice related to the application of legislation in the context of measures to combat the spread of COVID-19 No.3¹ (“Review”), paid special attention to issues in the field of tourism and air transportation.

On February 17, 2021, The Presidium of the Supreme Court approved the Review on certain matters of judicial practice in the context of measures to combat the spread of COVID-19 No.3¹ (“Review”). This is the third review by the Supreme Court containing legal positions on the application of law during a difficult sanitary and epidemiological situation.

March 18th 2021 Chambers and Partners Europe has announced the results of its annual research of the leading legal advisors. Lidings is traditionally highly recommended for Dispute Resolution, Corporate and M&A and Life Sciences advice in Russia.  The Firm’s Intellectual Property practice has also entered the ranking this year.